↓ Skip to main content

Cochrane Database of Systematic Reviews

Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy

Overview of attention for article published in Cochrane database of systematic reviews, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
126 Mendeley
Title
Allopurinol for preventing mortality and morbidity in newborn infants with hypoxic-ischaemic encephalopathy
Published in
Cochrane database of systematic reviews, July 2012
DOI 10.1002/14651858.cd006817.pub3
Pubmed ID
Authors

Tejasvi Chaudhari, William McGuire

Abstract

Delayed neuronal death following a perinatal hypoxic insult is due partly to xanthine oxidase-mediated production of cytotoxic free radicals. Evidence exists that allopurinol, a xanthine-oxidase inhibitor, reduces delayed cell death in experimental models of perinatal asphyxia and in people with organ reperfusion injury.

Mendeley readers

The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Poland 1 <1%
South Africa 1 <1%
Unknown 124 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 15%
Student > Master 18 14%
Researcher 15 12%
Student > Ph. D. Student 13 10%
Student > Postgraduate 12 10%
Other 26 21%
Unknown 23 18%
Readers by discipline Count As %
Medicine and Dentistry 60 48%
Nursing and Health Professions 11 9%
Neuroscience 5 4%
Agricultural and Biological Sciences 4 3%
Psychology 4 3%
Other 9 7%
Unknown 33 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2012.
All research outputs
#2,238,199
of 16,292,334 outputs
Outputs from Cochrane database of systematic reviews
#4,982
of 11,465 outputs
Outputs of similar age
#17,293
of 128,605 outputs
Outputs of similar age from Cochrane database of systematic reviews
#46
of 116 outputs
Altmetric has tracked 16,292,334 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,465 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.1. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,605 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.